Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.
2.

Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.

Rosental B, Brusilovsky M, Hadad U, Oz D, Appel MY, Afergan F, Yossef R, Rosenberg LA, Aharoni A, Cerwenka A, Campbell KS, Braiman A, Porgador A.

J Immunol. 2011 Dec 1;187(11):5693-702. doi: 10.4049/jimmunol.1102267.

3.

NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors.

Horton NC, Mathew PA.

Front Immunol. 2015 Feb 2;6:31. doi: 10.3389/fimmu.2015.00031. Review.

4.

Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.

Brusilovsky M, Radinsky O, Cohen L, Yossef R, Shemesh A, Braiman A, Mandelboim O, Campbell KS, Porgador A.

Eur J Immunol. 2015 Apr;45(4):1180-91. doi: 10.1002/eji.201445177.

5.

Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

Sivori S, Parolini S, Marcenaro E, Castriconi R, Pende D, Millo R, Moretta A.

J Neuroimmunol. 2000 Jul 24;107(2):220-5.

PMID:
10854660
6.

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.

Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A.

J Exp Med. 1998 Jun 15;187(12):2065-72.

7.
8.

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Nielsen N, Pascal V, Fasth AE, Sundström Y, Galsgaard ED, Ahern D, Andersen M, Baslund B, Bartels EM, Bliddal H, Feldmann M, Malmström V, Berg L, Spee P, Söderström K.

Immunology. 2014 Aug;142(4):581-93. doi: 10.1111/imm.12271.

9.

Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.

Tallerico R, Todaro M, Di Franco S, Maccalli C, Garofalo C, Sottile R, Palmieri C, Tirinato L, Pangigadde PN, La Rocca R, Mandelboim O, Stassi G, Di Fabrizio E, Parmiani G, Moretta A, Dieli F, Kärre K, Carbone E.

J Immunol. 2013 Mar 1;190(5):2381-90. doi: 10.4049/jimmunol.1201542.

10.

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.

Menier C, Riteau B, Carosella ED, Rouas-Freiss N.

Int J Cancer. 2002 Jul 1;100(1):63-70.

11.

Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria.

Esin S, Batoni G, Counoupas C, Stringaro A, Brancatisano FL, Colone M, Maisetta G, Florio W, Arancia G, Campa M.

Infect Immun. 2008 Apr;76(4):1719-27. doi: 10.1128/IAI.00870-07.

12.

Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.

Lo Monaco E, Tremante E, Cerboni C, Melucci E, Sibilio L, Zingoni A, Nicotra MR, Natali PG, Giacomini P.

Neoplasia. 2011 Sep;13(9):822-30.

13.

Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation.

Marras F, Nicco E, Bozzano F, Di Biagio A, Dentone C, Pontali E, Boni S, Setti M, Orofino G, Mantia E, Bartolacci V, Bisio F, Riva A, Biassoni R, Moretta L, De Maria A.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11970-5. doi: 10.1073/pnas.1302090110.

14.

Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.

Kuroki M, Hachimine K, Huang J, Shibaguchi H, Kinugasa T, Maekawa S, Kuroki M.

Anticancer Res. 2005 Nov-Dec;25(6A):3725-32. Review.

15.

The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering.

Bottino C, Biassoni R, Millo R, Moretta L, Moretta A.

Hum Immunol. 2000 Jan;61(1):1-6. Review.

PMID:
10658972
16.

HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.

Baudhuin J, Lesport E, Sousa S, Migraine J, Vigneron J, Lemaoult J, Carosella ED, Mooney N, Favier B.

Eur J Immunol. 2012 Mar;42(3):700-9. doi: 10.1002/eji.201141930.

17.

Analysis of HLA-E expression in human tumors.

Marín R, Ruiz-Cabello F, Pedrinaci S, Méndez R, Jiménez P, Geraghty DE, Garrido F.

Immunogenetics. 2003 Feb;54(11):767-75.

PMID:
12618909
18.
19.

Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.

Takayama T, Kamada N, Chinen H, Okamoto S, Kitazume MT, Chang J, Matuzaki Y, Suzuki S, Sugita A, Koganei K, Hisamatsu T, Kanai T, Hibi T.

Gastroenterology. 2010 Sep;139(3):882-92, 892.e1-3. doi: 10.1053/j.gastro.2010.05.040.

PMID:
20638936
20.

Strategies to endow cytotoxic T lymphocytes or natural killer cells with antibody activity against carcinoembryonic antigen.

Kuroki M, Kuroki M, Shibaguchi H, Badran A, Hachimine K, Zhang J, Kinugasa T.

Tumour Biol. 2004 Jul-Aug;25(4):208-16.

PMID:
15557759
Items per page

Supplemental Content

Support Center